KalVista Pharmaceuticals, Inc.KALVNASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-160.32M
↓ 134% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-68.63M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-160.32M | -4.6% |
| 2025 | $-153.34M | -71.0% |
| 2024 | $-89.67M | -17.3% |
| 2023 | $-76.46M | +3.3% |
| 2022 | $-79.06M | -161.3% |
| 2021 | $-30.25M | +32.8% |
| 2020 | $-45.04M | -20.3% |
| 2019 | $-37.45M | -510.1% |
| 2018 | $9.13M | +138.4% |
| 2017 | $-23.80M | - |